About Pyrls
Pyrls is a company based in Minneapolis (United States) founded in 2018 by Derek Borkowski. Pyrls has raised $125 thousand across 1 funding round from investors including Y Combinator. Pyrls offers products and services including Pyrls iOS App, Pyrls Android App, Drug Summaries, Pharmacotherapy Reviews, and Drug Interactions Tools. Pyrls operates in a competitive market with competitors including AccuRx, MedAware, YouScript, Ameritox and Bainbridge Health, among others.
- Headquarter Minneapolis, United States
- Founders Derek Borkowski
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cosmas Health, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$125 K (USD)
in 1 rounds
-
Latest Funding Round
$125 K (USD), Seed
Jun 01, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pyrls
Pyrls offers a comprehensive portfolio of products and services, including Pyrls iOS App, Pyrls Android App, Drug Summaries, Pharmacotherapy Reviews, and Drug Interactions Tools.
App providing drug summaries and tools for clinicians on iPhone devices.
App for accessing drug information and assessments on Android.
Concise overviews of medications with clinical and counseling points.
Reviews of guidelines for managing disease states with charts.
Fast interface for reviewing and explaining drug interactions.
People of Pyrls
Unlock access to complete
Unlock access to complete
Funding Insights of Pyrls
Pyrls has successfully raised a total of $125K through 1 strategic funding round. The most recent funding activity was a Seed round of $125 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pyrls
Pyrls has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked |
Investor details for Pyrls
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pyrls
Investment portfolio details for Pyrls
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pyrls
Detailed financials for Pyrls
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pyrls Comparisons
Peer comparison for Pyrls
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pyrls
Pyrls operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AccuRx, MedAware, YouScript, Ameritox and Bainbridge Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Platform to increase antibiotic prescribing accuracy in primary care
|
|
| Locked | Locked | Locked |
Provider of an AI based medication dosage and safety managing software for healthcare professionals
|
|
| Locked | Locked | Locked |
Clinical decision support software for drug interactions is developed.
|
|
| Locked | Locked | Locked |
Pain medication monitoring solutions are provided for US clinicians.
|
|
| Locked | Locked | Locked |
Provider of a clinical intelligence data analytics platform to monitor patient safety and reduce medication errors
|
Detailed competitors of Pyrls
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pyrls
Complete news archive for Pyrls
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pyrls
Pyrls was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Pyrls is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Derek Borkowski is the current CEO of Pyrls. They have also founded this company.
Pyrls is a funded company, having raised a total of $125K across 1 funding round to date.
Cloud-based practical drug information platform for providers. The company has developed a platform that enables users to get information on drug summaries, clinical use, charts, and more. The platform has features for drug interaction checkers, tables, and figures.
Pyrls offers Pyrls iOS App, Pyrls Android App, Drug Summaries, Pharmacotherapy Reviews, and Drug Interactions Tools.
Pyrls has 1 investor. Key investors include Y Combinator.